Latest filing published 10 Jan 2006 for BARR PHARMACEUTICALS INC, €44k.
Insider track record
No signal scores available.
Salah Amed: trading record in brief
Salah Amed is a declared insider of Barr Pharmaceuticals Inc, with filings sourced from SEC (Form 4). Between 4 January 2006 and 10 January 2006, the trades on record add up to 8 filings.
The open-market record consists of 3 sales worth €4.2M, with no purchase. Other entries cover 5 share grants.
Most recently, on 10 January 2006, the filings show a share grant worth €44k in Barr Pharmaceuticals Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Salah Amed
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,804 shares@ US$11.06Common StockSEC:0001209191-06-002871:0
- 4,804 shares@ US$66.54Common StockSEC:0001209191-06-002871:1
- 45,800 shares@ US$11.06Common StockSEC:0001209191-06-002871:2
- 45,800 shares@ US$66.62Common StockSEC:0001209191-06-002871:3
- 34,978 shares@ US$5.71Common StockSEC:0001209191-06-002039:0
- 2,737 shares@ US$11.75Common StockSEC:0001209191-06-002039:1
- 23,800 shares@ US$10.05Common StockSEC:0001209191-06-002039:2
- 26,537 shares@ US$63.25Common StockSEC:0001209191-06-002039:3
8 of 8 declarations
